Comparative assessment of Plasmodium falciparum sensitivity to chloroquine and amodiaquine in vitro

African Journal of Biotechnology

Volumn 4, Issue 11, 2005, Pages 1317-1320

  Oyedeji, Segun Isaac ^a   Bassi, Peter Usman ^b   Awobode, Henrietta Oluwatoyin ^c   Olumese, Peter Ehibizue ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF MAIDUGURI   (Nigeria)

^c UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Amodiaquine; Chloroquine; In vitro; Plasmodium falciparum; Resistance

Indexed keywords

AMODIAQUINE; CHLOROQUINE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; COMPARATIVE STUDY; DRUG ACTIVITY; DRUG RESISTANCE; FEMALE; HOST SUSCEPTIBILITY; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MATURATION; NIGERIA; PLASMODIUM FALCIPARUM; SCHIZONT; SCHOOL CHILD; WORLD HEALTH ORGANIZATION;

PLASMODIUM FALCIPARUM;

EID: 27744532381     PISSN: 16845315     EISSN: 16845315     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Brasseur P, Guiguemde R, Diallo S, Guiyedi V, Kombila M, Ringwald, P, Olliaro P (1999). Amodiaquine remains effective for treating uncomplicated malaria in West and Central Africa. Trans Roy. Soc.Trop. Med. Hyg. 93: 645 - 650.
2. Jensen JB, Trager W (1977). Plasmodium falciparum in continuous culture: Use of outdated erythrocytes and the description of the candle jar. J. Parasitol. 63: 883 - 886.
3. Noedl H, Wongsrichanalai C, Wernsdorfer WH (2003). Malaria drugsensitivity testing: New assay, new perspectives. Trends in Parasitol. 19: 175-181.
4. Olliaro O, Nevils C, Ringwald P, Mussano P, Garner P, Brasseur P (1996). Systematic review of amodiaquine treatment in uncomplicated malaria, Lancet 348: 1196 - 1201.
5. Phillips-Howard PA, West LJ (1990). Serious adverse drug reactions to pyrimethamine- sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain. J. Roy. Soc. Med. 83: 82-85.
6. Salako LA, Ajayi FO, Sowunmi A, Walker O (1990). Malaria in Nigeria:a revisit. Ann. Trop. Med. Parasitol. 84: 641 - 643.
7. Salako LA, Aderounmu AF (1987). In vitro chloroquine and mefloquine resistant plasmodium falciparum in Nigeria. Lancet ii: 572-573.
8. Spencer HC, Kipinger T, Agure R, Koech DK, Chulay JD (1983).Plasmodium falciparum in Kisumu, Kenya: Differences in sensitivity to Amodiaquine and Chloroquine in-vitro. J. Infectious Dis. 148 (4): 732-736.
9. Sowunmi A, Ayede AI, Falade AG, Ndikum VN, Sowunmi CO, Adedeji AA, Falade CO, Happi TC, Oduola AMJ (2001). Randomized comparison of chloroquine and amodiaquine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children.Ann. Trop. Med. Parasitol. 95: 549-558.
10. Staedke SG, Kamya, MR, Dorsey G, Gasasira A, Ndeezi G, Charlebois ED, Rosenthal PJ, (2001). Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: A randomised trial. Lancet 358: 368-374.
11. Sowunmi A, Oduola AMJ (1998). Validity of plasmodium falciparum exvivo: comparison of the effects of artemether and sulfadoxine pyrimethamine. Eur. J. Clin. Pharmacol. 54: 221-226.
12. Sowunmi A, Oduola AMJ (1997). Comparative efficacy of chloroquine/chlorpheniramine combination and mefloquine for the treatment of chloroquine-resistant plasmodium falciparum malaria in Nigerian children. Trans. Roy. Soc. Trop. Med. Hyg. 91: 689-693.
13. Wernsdorfer WH, Wernsdorfer MG (1995). The evaluation of in vitro test for the assessment of drug response in plasmodium falciparum. Parasitology 17: 221 - 227.
14. White NJ (1992). Antimalarial drug resistance:The pace quickens. J.Antimicrobial Chemother. 30: 571-585.
15. WHO/MAP/90.1. WHO (1996). World situation in 1993. Part 1. Weekly Epidemiological Record 71: 17-22.
16. WHO (1987). In-vitro micro-test (mark 11) for the assessment and response of Plasmodium falciparum to chlroquine. Quinine, ,sulphodoxine/pyrimethamine and amodiaquine,WHO/MAP/87,2.
17. WHO (1990a). Practical Chemotherapy of malaria: Report of a WHO Scientific Group. Tech. Rep. Series 805.
18. WHO (1990b). In vitro micro-test (Mark III) for the assessment of the response of plasmodium falciparum to chloroquine, mefloquine, quinine, sulfadoxine/ pyrimethamine and amodiaquine.